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ABSTRACT 
Background: Sleep duration has been shown to be associated with all-cause 
mortality, however its relationship with cause-specific fatal events remains uncertain. 
We examined the relationship between sleep duration and risk of fatal coronary heart 
disease (CHD), sudden cardiac death, cancer related death and all-cause mortality. 
Methods Sleep duration was self-reported at baseline examinations performed 
between March 20, 1984 and December 5, 1989 in 2,361 men aged 42-61 years old 
from the Kuopio Ischemic Heart Disease study. Of these 1734 (73.4%) men were 
free from CHD and cancer at baseline. 
Results: A total of 802 all cause deaths, 202 fatal coronary heart disease events, 
141 sudden cardiac events and 229 cancer related deaths were reported during a 
median follow-up of 25.9 (IQR: 20.6-28.2) years. Multi-variable adjusted hazard 
ratios (HR) comparing the top quartile (> 10 hours) of sleep duration versus the 
bottom quartile (<8 hours) was 1.19 (95% CI: 1.01-1.43) for all-cause mortality, 1.27 
(95% CI: 0.88-1.84) for fatal coronary heart disease, 1.20 (95% CI: 0.78-1.86) for 
sudden cardiac death and 1.29 (95% CI: 0.92-1.80) for cancer death. No differences 
in association of sleep duration with outcomes were found in clinically relevant 
subgroups including age, history of coronary heart disease, body mass index, 
physical activity, and C-reactive protein levels.  
Conclusion: Longer duration of sleep was associated with significantly increased 
all-cause mortality. Mechanistic link between these findings remains to be explored 
further. 
 
Key words: sudden cardiac death; coronary heart disease; cancer death; sleep 
duration. 
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Introduction: 
Sleep duration and its impact on health outcomes has received considerable 
attention in recent times 1. Several studies have demonstrated the association of 
sleep duration with incident diabetes mellitus, cardiovascular disease and obesity 2-4. 
Similarly it has also been associated with increased all-cause mortality, as several 
studies have reported a non-linear yet significant relationship between sleep duration 
and all-cause mortality5,6. However, data remains inconsistent in regards to sleep 
duration and cause-specific mortality 2,7. 
 
With changing sleep trends globally, due to the increased work hours, shift work and 
necessity of 24 hour availability across several professions, it has become 
increasingly important to examine the relationship between sleep and health 
outcomes. These relationships have potential important health implications and may 
guide future policies in health care sector. We report the association of self-reported 
sleep duration with risk of fatal coronary heart disease, sudden cardiac death, cancer 
related death and all-cause mortality in a large cohort of healthy middle aged men, 
prospectively followed for over two decades. 
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Methods 
Study population  
The study population is a representative sample of men living in the city of Kuopio 
and its surrounding rural communities in Eastern Finland. Subjects were participants 
in the Kuopio Ischaemic Heart Disease Risk Factor Study, a longitudinal population-
based study designed to investigate risk factors for cardiovascular disease, 
atherosclerosis, and related outcomes 8. The men were 42-61 years of age during 
baseline examinations performed between March 20, 1984 and December 5, 1989. 
Of 3,235 potentially randomly selected eligible men, 2,682 (83 %) volunteered to 
participate in this study, 186 did not respond to the invitation, and 367 declined to 
give informed consent. Individuals with preexisting coronary heart disease or cancer 
at baseline were excluded from the analysis (N=709). This was done so as to avoid 
bias due to reverse causation. That is individuals who have heart disease may be 
prone to sleep more or less due to their disease state than vice versa. The present 
analysis is based on 1,734 men with no missing data on, covariates, all-cause 
mortality, fatal coronary events, sudden cardiac death and cancer related death. The 
study was approved by the Research Ethics Committee of the University of Eastern 
Finland, and each participant gave written informed consent.  
 
Assessment of sleep duration and risk factors 
Sleep duration was self-reported at baseline examinations. The lifelong exposure to 
smoking (cigarette pack-years) was estimated as the product of the number of years 
smoked and the number of tobacco products smoked daily. Resting blood pressure 
was measured between 8 and 10 AM with a random-zero sphygmomanometer.  
Alcohol consumption was assessed using the Nordic Alcohol Consumption 
Inventory.  Body mass index (BMI) was computed as the ratio of weight in kilograms 
to the square of height in meters. Diabetes was defined as a fasting blood glucose 
level greater than 121 mg/dl (>6.7 mmol/L) or clinical diagnosis of diabetes with 
dietary, oral, or insulin treatment. The collection of blood specimens and the 
measurement of serum lipids, lipoproteins, creatinine, C-reactive protein and glucose 
have been described elsewhere9,10  
 
Definition of Follow-up Events 
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All-cause, coronary heart disease and cancer related deaths that occurred by the 
end of 2014 were checked against the hospital documents, health centres and death 
certificates. Incident cancer cases were derived from the population-based Finnish 
Cancer Registry11. There were no losses to follow-up. A death was classified as 
sudden cardiac death when it occurred within 24 hours of the onset of symptoms 
including non-witnessed cases when clinical and autopsy findings did not reveal a 
non-cardiac cause of sudden death. The unwitnessed subject was to have been 
seen alive and symptom free within 24 hours before the event12. Sudden cardiac 
deaths that occurred in out-of-hospital conditions were also defined as places in 
which the events occurred had been reported accurately in hospital documents. The 
deaths due to aortic aneurysm rupture, cardiac rupture or tamponade and pulmonary 
embolism were not included as sudden cardiac death. The sources of information 
were interviews, hospital documents, death certificates, autopsy reports and medico-
legal reports. The diagnostic classification of events was based on symptoms, 
electrocardiographic findings, cardiac enzyme elevations, autopsy findings (80%) 
and history of coronary heart disease together with the clinical and 
electrocardiographic findings of the paramedic staff. All the documents related to the 
death were cross-checked in detail by two physicians. Non- sudden cardiac deaths 
were also carefully documented using standardized criteria. Cardiac deaths that did 
not lead to death during the following 24 hours of the onset of symptoms were 
considered as non- sudden cardiac death. Data on incident acute coronary events 
were obtained by computer linkage to the national hospital registers. The 
independent events committee, blind to clinical data, performed the classification of 
deaths13.  
 
Statistical analyses 
Values of skewed variables were log-transformed to achieve approximately 
symmetrical distributions. Descriptive analyses summarized baseline characteristics 
by participants within quartiles of sleep duration. Cross-sectional associations of 
sleep duration with several risk factors were assessed using linear regression 
models adjusted for age. The primary outcomes were all-cause mortality, fatal 
coronary heart disease, sudden cardiac death and cancer related death. Cumulative 
survival plots were constructed for cause specific fatal events across quartiles of 
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sleep duration and compared with the log rank test. Time-to-event analyses were 
conducted using Cox proportional hazards models to examine the association of 
sleep duration with fatal outcomes after confirming that the assumption of 
proportionality of hazards was met. All models were adjusted for age and 
subsequently adjusted for body mass index, systolic blood pressure, history of 
diabetes, systolic blood pressure, serum LDL-c, serum creatinine and physical 
activity. The shape of the association with cause specific fatal outcomes was 
assessed by plotting hazard ratios (HRs) calculated within quartiles of baseline sleep 
duration against the mean sleep duration within each quartile.14 Furthermore, 
multivariate fractional polynomial models were also fitted to assess the shape of the 
association. Subgroup analyses were conducted using interaction tests to assess 
statistical evidence of any differences in HRs across levels of pre-specified individual 
level characteristics age at survey, prevalent CVD, body mass index, physical 
activity, and inflammatory markers such as C-reactive protein levels). Al l  s tatistical 
analyses were conducted using Stata version 12 (Stata Corp, College Station, 
Texas)15.  
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Results 
Baseline characteristics 
The mean age of participants at baseline was 51.7 (SD 5.6) years. The average 
sleep duration was 9.1 (SD 2.0) hours, (Supplementary Figure-1). Baseline 
descriptive characteristics of the participants according to quartiles of sleep duration 
are shown in Table 1.  
 
During a median follow-up of 25.9 (IQR: 20.6-28.2)  years, there were 802 all cause 
deaths, 202 fatal coronary heart disease events, 141 sudden cardiac events and 
229 cancer related deaths reported. At baseline, sleep duration was significantly 
lower in men with prevalent coronary heart disease at baseline, current smokers, 
subjects with prevalent diabetes, and those with a history of hypertension at baseline 
(Supplementary Table 1). Somewhat weaker but significant correlations were 
observed with body mass index (r=0.05), systolic blood pressure (r=0.08), total 
cholesterol (r=-0.06), high-density lipoprotein cholesterol (r=-0.06), LDL cholesterol 
(r=0.07) and serum C=reactive protein (r=0.10). 
 
Sleep duration and cause specific mortality 
Cumulative survival curves demonstrated a significant association of all cause, 
coronary heart disease, sudden cardiac death and cancer death in the top quartile of 
sleep duration compared to those in the bottom quartile (P-value for log rank test 
<0.001: Figure-1). Age-adjusted hazard ratio (HR) comparing the top quartile (> 10 
hours) of sleep duration versus the bottom quartile (<8 hours) was 1.36 (95% CI: 
1.13-1.62) for all-cause mortality, 1.56 (95% CI: 1.08-2.24) for coronary heart 
disease, 1.47 (95% CI: 0.96-2.26) for sudden cardiac death and 1.39 (95% CI: 1.0-
1.94) for cancer death. Further adjustment for risk factors including systolic blood 
pressure, history of cardiovascular disease, diabetes, smoking, alcohol use, renal 
function and serum LDL cholesterol attenuated these associations further to 1.19 
(95% CI: 1.01-1.43) for all-cause mortality, 1.27 (95% CI: 0.88-1.84) for fatal 
coronary heart disease, 1.20 (95% CI: 0.78-1.86) for sudden cardiac death and 1.29 
(95% CI: 0.92-1.80) for cancer death . Progressive adjustments for physical activity 
and serum C-reactive protein did not attenuate these associations, Table 2. Sleep 
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duration was non-linearly associated with all-cause mortality, fatal coronary heart 
disease and cancer death, Figure-2. No differences in association of sleep duration 
with outcomes were found in clinically relevant subgroups (Supplementary Figure-
2). Further evaluation of cause specific cancer outcomes found significant 
association with gastrointestinal cancer subtype 1.71(95% 1.13-2.55) comparing top 
versus bottom quartile for sleep duration (Figure-3).  
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Discussion: 
In this large prospective cohort, sleep duration was significantly associated with all-
cause mortality. We also report significant associations with fatal coronary heart 
disease and cancer events which were attenuated on further adjustment.  
The association of sleep duration with all-cause mortality has been extensively 
documented, with both short and long sleepers noted to be at higher risk 5,6. Sleep 
duration has been associated with diabetes mellitus, lower physical activity, 
depression, hypertension and smoking, which in turn increase the overall risk of 
mortality 16-18. Moreover longer sleep duration may be a manifestation of a clinical 
disorder rather than a causal risk factor, such as obstructive sleep apnea. It may also 
reflect difficulty in falling asleep which has been associated with increased risk of 
coronary heart disease mortality 19. Retrospective studies have linked sleep duration 
to clinical coronary heart disease 20. However, studies examining the association 
between sleep duration and cardiovascular disease mortality have yielded mixed 
results, with most suggesting a J or U-shaped relationship and the association was 
attenuated to some extent after adjusting for confounders 2. In a prospective study, 
sleep duration of 6-8 hours/day was found to be one of the protective lifestyle factors 
against cardiovascular disease related mortality 21. There was a significant 
association between longer sleep duration and fatal coronary heart disease in the 
present study. The prospective nature of our study allowed us to control for several 
cardiovascular risk factors, which have not been comprehensively accounted for in 
many of the retrospective studies. 
Our findings are also in line with a large meta-analysis of prospective studies that 
showed that long, not short duration of sleep was significantly associated with 
increased cancer related mortality 7. We here further explored cancer specific 
mortality data and found that gastrointestinal cancer subtype was significantly 
associated with mortality. Long sleep duration has been associated with colorectal 
cancer, but the association was limited to overweight individuals or whom snored 
regularly, suggesting hypoxemia due to sleep apnea contributing to the increased 
risk 22. Long sleep duration has been related to systemic inflammation, increase in 
cytokines and change in several metabolic pathways23. In the present study 
adjustments for CRP did not attenuate the association of sleep duration with cancer 
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mortality, suggesting that the relationship is independent of inflammatory response. 
The lack of physiological challenge due to increased sleep has also been proposed 
as a mechanism that may increase mortality 24. Longer sleep duration has also been 
linked to depression and other psychiatric disorders, which are known to be 
associated with increased all-cause as well as CVD and cancer-specific mortality 
events 25-27. The change in photoperiod has been shown to accelerate ageing and 
increase mortality in mammalian species 28. However all these proposed 
mechanisms are speculative at best and require more research. 
This study is best understood in the context of its limitations. The study population 
involved only middle-aged men from eastern Finland, thus generalizability of the 
results to other age groups, populations and women may not be possible. Of note, 
the average sleep duration in our study was 9.1 hours with the lowest quartile being 
8.2 hours. This is longer compared to previously reported data from western 
population. Sleep duration was self-reported and did not account for quality of sleep 
or nocturnal vs. diurnal timing of the sleep. However, an objective measurement of 
sleep duration and quality, such as polysomnography is not practical in large-scale 
population-based cohorts. We were unable to evaluate individuals with shorter 
duration of sleep <5 hrs as less than 1% of the cohort slept less than 5 hours. 
Further prospective studies are needed to investigate the mechanistic link and to 
determine if duration of sleep is a modifiable risk factor or not.  
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